Within Major Pharmaceutical Preparations industry Acura Pharmaceuticals inc booked the highest Quick Ratio than Acura Pharmaceuticals Inc in the fourth quarter 2021. While total ranking remained the same in the Q4 2021 compared to the third quarter 2021 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents ACUR�s has?
What are ACUR�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ACUR Quick Ratio	(Dec 31 2021) Q4	(Sep 30 2021) Q3	(Jun 30 2021) Q2	(Mar 31 2021) Q1	(Dec 31 2020) Q4
Y / Y Current Liabilities Change	-93.15 %	-17.3 %	-84.95 %	5.13 %	783.9 %
Y / Y Cash & cash equivalent Change	-	-	-	-	-
Quick Ratio MRQ	-	-	-	-	-
ACUR's Total Ranking	#	#	#	#	#
Seq. Current Liabilities Change	-47.45 %	-11.71 %	-85.55 %	2.15 %	534.77 %
Seq. Cash & cash equivalent Change	-	-	-	-	-

Quick Ratio fourth quarter 2021 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Quick Ratio Statistics
High	Average	Low
0	0	0

Financial Statements
Acura Pharmaceuticals Inc's Current Liabilities	$ 1 Millions	Visit ACUR's Balance sheet
Acura Pharmaceuticals Inc's Cash & cash equivalent	$ 0 Millions	Visit ACUR's Balance sheet
Source of ACUR's Sales		Visit ACUR's Sales by Geography

Cumulative Acura Pharmaceuticals Inc's Quick Ratio

ACUR's Quick Ratio for the trailling 12 Months

ACUR Quick Ratio	(Dec 31 2021) 12 Months	(Sep 30 2021) 12 Months	(Jun 30 2021) 12 Months	(Mar 31 2021) 12 Months	(Dec 31 2020) 12 Months
Y / Y Current Liabilities TTM Growth	-56.01 %	3.44 %	5.56 %	124.72 %	144.5 %
Y / Y Cash & cash equivalent TTM Growth	-	-	-	-	-
Quick Ratio TTM	-	-	-	-	-
Total Ranking TTM
Seq. Current Liabilities TTM Growth	-40.51 %	-1.17 %	-26.36 %	1.6 %	39.9 %
Seq. Cash & cash equivalent TTM Growth	-	-	-	-	-

Quick ratio ranking by company, industry and sector >> Back to ACUR Financial Strength Comparisons >> Go to Compare ACUR Quick Ratio to its Competitors

On the trailing twelve months basis
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry ACUR achieved the highest Quick Ratio. While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents ACUR�s has?
What are ACUR�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Within the Market	#

trailing twelve months Quick Ratio Statistics
High	Average	Low
0	0	0

Companies with similar Quick Ratio in the quarter ending Dec 31 2021, within Major Pharmaceutical Preparations Industry

Quick Ratio

Dec 31 2021 MRQ Cash & cash equivalent

Dec 31 2021 MRQ Current Liabilities

Date modified: 2026-09-18T13:11:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.